FR2839722A1 - Nouvelles compositions peptidiques et leur utilisation notamment dans la preparation de compositions pharmaceutiques actives contre le virus de l'hepatite c - Google Patents

Nouvelles compositions peptidiques et leur utilisation notamment dans la preparation de compositions pharmaceutiques actives contre le virus de l'hepatite c

Info

Publication number
FR2839722A1
FR2839722A1 FR0206111A FR0206111A FR2839722A1 FR 2839722 A1 FR2839722 A1 FR 2839722A1 FR 0206111 A FR0206111 A FR 0206111A FR 0206111 A FR0206111 A FR 0206111A FR 2839722 A1 FR2839722 A1 FR 2839722A1
Authority
FR
France
Prior art keywords
peptide
virus
preparation
compositions
active against
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
FR0206111A
Other languages
English (en)
French (fr)
Inventor
Anne Fournillier
Nourredine Himoudi
Genevieve Inchauspe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biomerieux SA
Institut National de la Sante et de la Recherche Medicale INSERM
Original Assignee
Biomerieux SA
Institut National de la Sante et de la Recherche Medicale INSERM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=29286584&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FR2839722(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Biomerieux SA, Institut National de la Sante et de la Recherche Medicale INSERM filed Critical Biomerieux SA
Priority to FR0206111A priority Critical patent/FR2839722A1/fr
Priority to ES03752815T priority patent/ES2268411T5/es
Priority to DK03752815.5T priority patent/DK1506225T4/da
Priority to EP03752815A priority patent/EP1506225B2/fr
Priority to PT03752815T priority patent/PT1506225E/pt
Priority to DE60306771T priority patent/DE60306771T3/de
Priority to AU2003255577A priority patent/AU2003255577A1/en
Priority to PCT/FR2003/001478 priority patent/WO2003097677A2/fr
Priority to AT03752815T priority patent/ATE332921T1/de
Priority to JP2004506350A priority patent/JP4309837B2/ja
Priority to US10/514,762 priority patent/US7393831B2/en
Priority to CN038111349A priority patent/CN1653086B/zh
Publication of FR2839722A1 publication Critical patent/FR2839722A1/fr
Priority to US11/503,245 priority patent/US20070072176A1/en
Priority to US12/132,321 priority patent/US8080525B2/en
Priority to US12/211,385 priority patent/US8067228B2/en
Priority to US12/653,751 priority patent/US8293528B2/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
FR0206111A 2002-05-17 2002-05-17 Nouvelles compositions peptidiques et leur utilisation notamment dans la preparation de compositions pharmaceutiques actives contre le virus de l'hepatite c Withdrawn FR2839722A1 (fr)

Priority Applications (16)

Application Number Priority Date Filing Date Title
FR0206111A FR2839722A1 (fr) 2002-05-17 2002-05-17 Nouvelles compositions peptidiques et leur utilisation notamment dans la preparation de compositions pharmaceutiques actives contre le virus de l'hepatite c
CN038111349A CN1653086B (zh) 2002-05-17 2003-05-15 新的肽组合物以及它们在制备抗丙肝病毒药物组合物中的用途
AT03752815T ATE332921T1 (de) 2002-05-17 2003-05-15 Neue peptidzusammensetzungen und deren verwendung,insbesondere zur herstellung von pharmazeutischen zusammensetzungen mit wirkung gegen das hepatitis-c-virus
US10/514,762 US7393831B2 (en) 2002-05-17 2003-05-15 Peptide compositions and their use against HCV
EP03752815A EP1506225B2 (fr) 2002-05-17 2003-05-15 Nouvelles compositions peptidiques et leur utilisation notamment dans la preparation de compositions pharmaceutiques actives contre le virus de l'hepatite c
PT03752815T PT1506225E (pt) 2002-05-17 2003-05-15 Novas composições peptídicas e sua utilização, especialmente na preparação de composições farmacêuticas activas contra o vírus da hepatite c
DE60306771T DE60306771T3 (de) 2002-05-17 2003-05-15 Neue peptidzusammensetzungen und deren verwendung, insbesondere zur herstellung von pharmazeutischen zusammensetzungen mit wirkung gegen das hepatitis-c-virus
AU2003255577A AU2003255577A1 (en) 2002-05-17 2003-05-15 Novel peptide compositions and the use thereof, in particular, in the preparation of active pharmaceutical compositions against the hepatitis c virus
PCT/FR2003/001478 WO2003097677A2 (fr) 2002-05-17 2003-05-15 Nouvelles compostions peptidiques et leur utilisation notamment dans la preparation de compositions pharmaceutiques actives contre le virus de l'hepatite c
ES03752815T ES2268411T5 (es) 2002-05-17 2003-05-15 Nuevas composiciones peptidicas y su utilizacion particularmente en la preparacion de composiciones farmaceuticas activas contra el virus de la hepatitis c.
JP2004506350A JP4309837B2 (ja) 2002-05-17 2003-05-15 新規なペプチド組成物及び特にｃ型肝炎ウイルスに対して有効な医薬組成物の製造におけるその使用
DK03752815.5T DK1506225T4 (da) 2002-05-17 2003-05-15 Hidtil ukendte peptidsammensætninger og anvendelse deraf i fremstillingen af aktive farmaceutiske sammensætninger mod hepatitis c-virus
US11/503,245 US20070072176A1 (en) 2002-05-17 2006-08-11 Novel peptide compositions and their use in particular in the preparation of pharmaceutical compositions active against the hepatitis C virus
US12/132,321 US8080525B2 (en) 2002-05-17 2008-06-03 Peptide compositions and their use against the hepatitis C virus
US12/211,385 US8067228B2 (en) 2002-05-17 2008-09-16 Nucleic acid compositions and their use against the hepatitic C virus
US12/653,751 US8293528B2 (en) 2002-05-17 2009-12-17 Peptide compositions and their use in particular in the preparation of pharmaceutical compositions active against the hepatitis C virus

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0206111A FR2839722A1 (fr) 2002-05-17 2002-05-17 Nouvelles compositions peptidiques et leur utilisation notamment dans la preparation de compositions pharmaceutiques actives contre le virus de l'hepatite c

Publications (1)

Publication Number Publication Date
FR2839722A1 true FR2839722A1 (fr) 2003-11-21

Family

ID=29286584

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0206111A Withdrawn FR2839722A1 (fr) 2002-05-17 2002-05-17 Nouvelles compositions peptidiques et leur utilisation notamment dans la preparation de compositions pharmaceutiques actives contre le virus de l'hepatite c

Country Status (12)

Country Link
US (5) US7393831B2 (enExample)
EP (1) EP1506225B2 (enExample)
JP (1) JP4309837B2 (enExample)
CN (1) CN1653086B (enExample)
AT (1) ATE332921T1 (enExample)
AU (1) AU2003255577A1 (enExample)
DE (1) DE60306771T3 (enExample)
DK (1) DK1506225T4 (enExample)
ES (1) ES2268411T5 (enExample)
FR (1) FR2839722A1 (enExample)
PT (1) PT1506225E (enExample)
WO (1) WO2003097677A2 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2862648A1 (fr) * 2003-11-21 2005-05-27 Biomerieux Sa Nouveau peptide immunogene et nouveaux epitopes et utilisations notamment dans la preparation de compositions pharmaceutiques actives contre le virus de l 'hepatite c

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2839722A1 (fr) 2002-05-17 2003-11-21 Bio Merieux Nouvelles compositions peptidiques et leur utilisation notamment dans la preparation de compositions pharmaceutiques actives contre le virus de l'hepatite c
FR2855758B1 (fr) * 2003-06-05 2005-07-22 Biomerieux Sa Composition comprenant la polyproteine ns3/ns4 et le polypeptide ns5b du vhc, vecteurs d'expression incluant les sequences nucleiques correspondantes et leur utilisation en therapeutique
US20080249283A1 (en) * 2004-04-30 2008-10-09 Tomoya Miyakawa Hla-Binding Peptides, Precursors Thereof, Dna Fragments and Recombinant Vectors that Code for Those Peptide Sequences
MX2008011361A (es) * 2006-03-09 2008-09-15 Transgene Sa Proteina de fusion no-estructural del virus de hepatitis c.
JP5031827B2 (ja) 2006-06-01 2012-09-26 程云 予防或いは肝損傷を治療するペプチッド
EP2646459B1 (en) 2010-12-02 2020-01-08 Bionor Immuno AS Peptide scaffold design

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0450931A1 (en) * 1990-04-04 1991-10-09 Chiron Corporation Combinations of hepatitis C virus (HCV) antigens for use in immunoassays for anti-HCV antibodies
EP0468527A2 (en) * 1990-07-26 1992-01-29 United Biomedical, Inc. Synthetic peptides specific for the detection of antibodies to HCV, diagnosis of HCV infection and prevention thereof as vaccines
WO1993000365A2 (en) * 1991-06-24 1993-01-07 Chiron Corporation Hepatitis c virus (hcv) polypeptides
US5736321A (en) * 1994-11-01 1998-04-07 United Biomedical, Inc. Peptides effective for diagnosis and detection of hepatitis C infection
WO1999067285A1 (en) * 1998-06-24 1999-12-29 Innogenetics N.V. Particles of hcv envelope proteins: use for vaccination
WO2001021189A1 (en) * 1999-07-19 2001-03-29 Epimmune Inc. Inducing cellular immune responses to hepatitis c virus using peptide and nucleic acid compositions
WO2001090197A1 (en) * 2000-05-26 2001-11-29 The Australian National University Synthetic peptides and uses therefore
WO2001092311A2 (fr) * 2000-05-26 2001-12-06 Societe D'etude Et De Developpement Des Antigenes Combinatoires - Sedac Therapeutics Bibliotheques peptidiques combinatoires convergentes et leur applicaton a la vaccination contre le virus de l'hepatite c

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US132321A (en) * 1872-10-15 Improvement in platform-scales
US4007844A (en) * 1976-02-02 1977-02-15 Maxon Industries, Inc. Self folding platform
US4087007A (en) * 1976-12-01 1978-05-02 Leyman Manufacturing Co. Cargo platform system
US4198188A (en) * 1977-04-07 1980-04-15 Perkins William V Load elevator mechanism for unstable loads
US4563121A (en) * 1983-02-22 1986-01-07 Leyman Manufacturing Corp. Cargo elevator system
US4576541A (en) * 1984-02-29 1986-03-18 Leyman Manufacturing Corp. Safety latch for a cargo platform
US4627784A (en) * 1986-01-21 1986-12-09 Venco Manufacturing, Inc. Loading and unloading apparatus for a vehicle
US4725185A (en) * 1986-05-12 1988-02-16 Maxon Industries, Inc. Fail safe brake for rail type lifts
US4806062A (en) * 1987-10-29 1989-02-21 Maxon Industries, Inc. Stowable lift for freight vehicles
US5683864A (en) * 1987-11-18 1997-11-04 Chiron Corporation Combinations of hepatitis C virus (HCV) antigens for use in immunoassays for anti-HCV antibodies
US4930969A (en) * 1988-08-11 1990-06-05 Langer Hartford P Rail lift gate apparatus and storage scheme
KR0185373B1 (ko) 1989-03-17 1999-05-01 로버트 피. 블랙버언 Hcv 폴리단백질에서 유래되는 hcv 아미노산 서열 부분을 포함하는 폴리펩티드 및 그 사용
US5106726A (en) * 1990-02-16 1992-04-21 United Biomedical, Inc. Synthetic peptides specific for the detection of antibodies to HCV
US5747239A (en) * 1990-02-16 1998-05-05 United Biomedical, Inc. Synthetic peptides specific for the detection of antibodies to HCV, diagnosis of HCV infection and preventions thereof as vaccines
US5639594A (en) * 1990-02-16 1997-06-17 United Biomedical, Inc. Linear and branched peptides effective in diagnosing and detecting non-A, non-B hepatitis
KR940000755B1 (ko) * 1990-02-16 1994-01-29 유나이티드 바이오메디칼 인코오포레이티드 Hcv에 대한 항체 검출, hcv 감염의 진단 및 백신으로서의 그 예방에 특히 적합한 합성 펩티드
US5582968A (en) * 1990-02-16 1996-12-10 United Biomedical, Inc. Branched hybrid and cluster peptides effective in diagnosing and detecting non-A, non-B hepatitis
US5712087A (en) * 1990-04-04 1998-01-27 Chiron Corporation Immunoassays for anti-HCV antibodies employing combinations of hepatitis C virus (HCV) antigens
US5157504A (en) 1990-04-20 1992-10-20 Fuji Photo Film Co., Ltd. Copy cassette supplying apparatus
US5122026A (en) * 1990-09-17 1992-06-16 Leyman Manufacturing Corp. Cargo platform with plural storage positions
US6274148B1 (en) * 1990-11-08 2001-08-14 Chiron Corporation Hepatitis C virus asialoglycoproteins
US5263808A (en) * 1991-11-27 1993-11-23 Leyman Manufacturing Corp. Automatic storage latch system for a cargo platform
BR9406652A (pt) 1993-03-05 1996-09-10 Cytel Corp Composição
US5709995A (en) * 1994-03-17 1998-01-20 The Scripps Research Institute Hepatitis C virus-derived peptides capable of inducing cytotoxic T lymphocyte responses
US5513943A (en) * 1994-05-16 1996-05-07 Tatcom, Inc. Load elevator with columnar power assemblies
US20030095980A1 (en) * 1994-07-29 2003-05-22 Geert Maertens Purified hepatitis C virus envelope proteins for diagnostic and therapeutic use
US5597282A (en) * 1995-08-29 1997-01-28 Leyman Manufacturing Corporation Method and apparatus for unstacking and unloading a stacked load from one level to another level
US6534482B1 (en) * 1998-05-13 2003-03-18 Epimmune, Inc. Expression vectors for stimulating an immune response and methods of using the same
ES2371432T3 (es) * 1998-05-13 2012-01-02 Epimmune Inc. Vectores de expresión para estimular una respuesta inmune y procedimientos de uso de los mismos.
US7108855B2 (en) * 1998-06-24 2006-09-19 Innogenetics N.V. Purified hepatitis C virus envelope proteins for diagnostic and therapeutic use
AU1236801A (en) * 1999-10-27 2001-05-08 Chiron Corporation Activation of hcv-specific t cells
AU2002219711B8 (en) 2000-12-08 2006-03-02 Academisch Ziekenhuis Leiden Long peptides of 22-45 amino acid residues that induce and/or enhance antigen specific immune responses
DE10131978A1 (de) * 2001-07-02 2003-01-30 Witte Velbert Gmbh & Co Kg Drehfallenverschluss
FR2839722A1 (fr) 2002-05-17 2003-11-21 Bio Merieux Nouvelles compositions peptidiques et leur utilisation notamment dans la preparation de compositions pharmaceutiques actives contre le virus de l'hepatite c
US7695960B2 (en) * 2003-06-05 2010-04-13 Transgene S.A. Composition comprising the polyprotein NS3/NS4 and the polypeptide NS5B of HCV, expression vectors including the corresponding nucleic sequences and their therapeutic use
US7172689B2 (en) * 2004-02-20 2007-02-06 Bratten Jack R Arrangement and method for maintaining a minimum flow velocity in the coolant return of a machine tool coolant filtration system
US7491026B2 (en) * 2005-03-17 2009-02-17 Saf-Holland, Inc. Lift gate assembly
US7484921B2 (en) * 2005-08-24 2009-02-03 Murphy Michael O Lift gate system

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0450931A1 (en) * 1990-04-04 1991-10-09 Chiron Corporation Combinations of hepatitis C virus (HCV) antigens for use in immunoassays for anti-HCV antibodies
EP0468527A2 (en) * 1990-07-26 1992-01-29 United Biomedical, Inc. Synthetic peptides specific for the detection of antibodies to HCV, diagnosis of HCV infection and prevention thereof as vaccines
WO1993000365A2 (en) * 1991-06-24 1993-01-07 Chiron Corporation Hepatitis c virus (hcv) polypeptides
US5736321A (en) * 1994-11-01 1998-04-07 United Biomedical, Inc. Peptides effective for diagnosis and detection of hepatitis C infection
WO1999067285A1 (en) * 1998-06-24 1999-12-29 Innogenetics N.V. Particles of hcv envelope proteins: use for vaccination
WO2001021189A1 (en) * 1999-07-19 2001-03-29 Epimmune Inc. Inducing cellular immune responses to hepatitis c virus using peptide and nucleic acid compositions
WO2001090197A1 (en) * 2000-05-26 2001-11-29 The Australian National University Synthetic peptides and uses therefore
WO2001092311A2 (fr) * 2000-05-26 2001-12-06 Societe D'etude Et De Developpement Des Antigenes Combinatoires - Sedac Therapeutics Bibliotheques peptidiques combinatoires convergentes et leur applicaton a la vaccination contre le virus de l'hepatite c

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2862648A1 (fr) * 2003-11-21 2005-05-27 Biomerieux Sa Nouveau peptide immunogene et nouveaux epitopes et utilisations notamment dans la preparation de compositions pharmaceutiques actives contre le virus de l 'hepatite c
WO2005051420A1 (fr) * 2003-11-21 2005-06-09 Transgene Sa Nouveau peptide immunogene et nouveaux epitopes et utilisations notamment dans la preparation de compositions pharmaceutiques actives contre le virus de l'hepatite c

Also Published As

Publication number Publication date
DK1506225T4 (da) 2010-07-05
US20070020285A1 (en) 2007-01-25
DE60306771T3 (de) 2010-09-30
ES2268411T5 (es) 2010-05-28
DE60306771D1 (de) 2006-08-24
PT1506225E (pt) 2006-12-29
WO2003097677A3 (fr) 2004-03-25
JP4309837B2 (ja) 2009-08-05
US8067228B2 (en) 2011-11-29
US20070072176A1 (en) 2007-03-29
AU2003255577A8 (en) 2003-12-02
DK1506225T3 (da) 2006-11-13
US20110020398A1 (en) 2011-01-27
US7393831B2 (en) 2008-07-01
WO2003097677A2 (fr) 2003-11-27
US8293528B2 (en) 2012-10-23
CN1653086A (zh) 2005-08-10
US20090087449A1 (en) 2009-04-02
US8080525B2 (en) 2011-12-20
US20090075879A1 (en) 2009-03-19
DE60306771T2 (de) 2007-08-09
ES2268411T3 (es) 2007-03-16
ATE332921T1 (de) 2006-08-15
JP2006511442A (ja) 2006-04-06
CN1653086B (zh) 2012-05-23
EP1506225B2 (fr) 2010-03-17
AU2003255577A1 (en) 2003-12-02
EP1506225B1 (fr) 2006-07-12
EP1506225A2 (fr) 2005-02-16

Similar Documents

Publication Publication Date Title
WO2001002424A3 (en) Peptide boronic acid inhibitors of hepatitis c virus protease
ATE254630T1 (de) Cyclosporine
JP2003503312A5 (enExample)
EA200200106A1 (ru) Фармацевтическая композиция леводопа/карбидопа/энтакапон
BR0115965A (pt) Composições farmacêuticas para a liberação oral de agentes farmacologicamente ativos
ID21956A (id) Asam n-(aril dan atau heteroarilasetil) amino ester, komposisi farmasi yang mengandungnya, dan metoda untuk menghambat pelepasan betha-amiloid peptida dan atau sintesanya dengan menggunakan senyawa tersebut
FR2738151B1 (fr) Antagonistes de l'activite oncogenique de la proteine mdm2, et leur utilisation dans le traitement des cancers
JP2006506942A5 (enExample)
TR200401793T4 (tr) Perindopril tuzu ve bunu içeren farmasötik bileşimler.
FR2842209B1 (fr) Nouvelle protease aspartique dite saspase et son utilisation dans le domaine cosmetique et therapeutique
JP2004521123A5 (enExample)
IT1299583B1 (it) Uso di proteine hmg-i per la preparazione di medicamenti ad attivita' citotossica
FR2839722A1 (fr) Nouvelles compositions peptidiques et leur utilisation notamment dans la preparation de compositions pharmaceutiques actives contre le virus de l'hepatite c
EA200501131A1 (ru) Парентеральные композиции пептидов для лечения системной красной волчанки
EA200400592A1 (ru) КОНЪЮГАТЫ ПЕПТИДА ТИМОЗИН α1 И ПОЛИМЕРА
CA2306441A1 (fr) Peptides issus de gene env du virus de l'immunodeficience feline et leurs applications
CA2448745A1 (en) Compositions based on amino acids for improving the myocardial ventricular function in patients suffering from diabetes
IT1320782B1 (it) Composizioni a base di aminoacidi, atte al trattamentodell'insufficienza cardiaca.
JOP20240271A1 (ar) ببتيدات إظهار أنشطة منع فقدان العضلات وتعزيز الكتلة العضلية واستخداماتها
ATE371737T1 (de) Proteaseresistente flint-analoge
FR2862648B1 (fr) Nouveau peptide immunogene et nouveaux epitopes et utilisations notamment dans la preparation de compositions pharmaceutiques actives contre le virus de l 'hepatite c
US5529983A (en) Use of small peptides in the treatment of psoriasis
ATE269101T1 (de) Rekombinantes sp-a zur behandlung und vorbeugung von pulmonaren infektionen und entzündungen
ATE417061T1 (de) Scorpionpeptid als blutdrucksenkendes mittel
CA2257973A1 (en) T cell antigen receptor peptides

Legal Events

Date Code Title Description
ST Notification of lapse
D3 Ip right revived
ST Notification of lapse

Effective date: 20070131